Chart: Numbers Don't Lie: Update on Citations of False and Misleading Advertising
Executive Summary
It's panning out to be a big year for advertising enforcement. The FDA Amendments Act infused new resources and authority into FDA's Division Drug Marketing, Advertising and Communication, allowing DDMAC to beef-up its operations and put more attention and resources into advertising enforcement ("The Pink Sheet," May 25, 2009, p. 3). Speaking at a June 22 session of the Drug Information Association annual meeting in San Diego, DDMAC Director Thomas Abrams gave an update of the division and its enforcement actions from June 2008 through May 2009.